Status:

COMPLETED

Self-monitoring of Blood Pressure in Primary Care

Lead Sponsor:

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

Collaborating Sponsors:

Heart and Stroke Foundation of Ontario

Conditions:

High Blood Pressure

Eligibility:

All Genders

30+ years

Phase:

NA

Brief Summary

This study is an open randomized controlled trial of 12-month duration, which compares the use of a home blood pressure (BP) tele-management system to the usual approach of home BP monitoring in older...

Detailed Description

Hypertension is a major risk factor for renal and cardiovascular disease (CVD). While the health benefits of lowering blood pressure (BP) are well documented, population surveys have consistently foun...

Eligibility Criteria

Inclusion

  • Diagnosis of type 2 diabetes mellitus (the onset of diabetes must have occurred on or after the age of 30 years and there is no history of diabetic ketoacidosis)
  • Uncontrolled systolic hypertension (defined as a daytime systolic BP of 130 mm Hg or higher on 24-hour ambulatory)

Exclusion

  • Conditions making the patient unsuitable for study such as severe cognitive impairment, language difficulties (unable to speak and understand instructions in English), frequent (more than once per month for more than week) or prolonged (more than 2 months) trips away from home, homelessness, self-identified substance abuse, being pregnant, or unable to use home BP device;
  • Life expectancy less than one year
  • Coexisting conditions that require frequent (more than once a month) office visits or repeated (more than once in the past year) hospitalizations
  • Atrial fibrillation or other cardiac arrhythmias requiring drug treatment
  • Moderately severe chronic renal failure defined as estimated GFR less than 25 mL/min
  • Myocardial infarction, episode of heart failure requiring hospitalization, or paralyzing stroke in the past year
  • Having unstable angina
  • Severe valvular heart diseases such as severe aortic stenosis
  • Symptomatic orthostatic hypotension
  • Refusal to sign consent form or to carry out the demands made by the study

Key Trial Info

Start Date :

June 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2010

Estimated Enrollment :

110 Patients enrolled

Trial Details

Trial ID

NCT00717665

Start Date

June 1 2007

End Date

June 1 2010

Last Update

June 28 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Mount Sinai Hospital

Toronto, Ontario, Canada, M5G 1X5